Login / Signup

The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.

Meng LiWenqi ZhangLinqi YangHuibing WangYihan WangKai HuangWei Zhang
Published in: Disease markers (2021)
Stigmasterol as the one of the main compounds of XYS suppresses OC cell activities through the PI3K-Akt signaling pathway.
Keyphrases
  • signaling pathway
  • single cell
  • pi k akt
  • epithelial mesenchymal transition
  • stem cells
  • combination therapy
  • mesenchymal stem cells